Can a simple needle biopsy replace surgery for thyroid cancer testing?
NCT ID NCT06133374
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a fine needle biopsy (a small sample taken with a thin needle) gives the same molecular classification results as a larger surgical sample in people with papillary thyroid cancer. About 130 adults with confirmed or suspected thyroid cancer will provide both sample types, and researchers will compare the results using the Thyroid GuidePx test. The goal is to see if the less invasive needle biopsy can reliably classify the cancer type, potentially reducing the need for surgery in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Foothills Medical Centre
RECRUITINGCalgary, Alberta, T2N 1N4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-Time tissue test may help surgeons avoid unnecessary neck dissections in thyroid cancer
- Hidden thyroid cancers: how common are they in patients with thyroiditis?
- New thyroid test aims to cut unnecessary surgeries
- Radioactive iodine: unnecessary for some thyroid cancer patients?
- Pee power: urine test could replace blood draws for thyroid cancer Follow-Up
- Urine test may spot hidden thyroid cancer, avoid unnecessary surgery